tiprankstipranks
Astellas Pharma Inc (JP:4503)
:4503
Japanese Market
4503
Astellas Pharma
RESEARCH TOOLSreports
Want to see JP:4503 full AI Analyst Report?

Astellas Pharma (4503) Income Statement

5 Followers

Astellas Pharma Income Statement

Last quarter (Q2 2026), Astellas Pharma's total revenue was ¥524.32B, an increase of 1.34% from the same quarter last year. In Q2, Astellas Pharma's net income was ¥79.21B. See Astellas Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 26Mar 25Mar 24Mar 23
Total Revenue
¥ 1.91T¥ 2.14T¥ 1.60T¥ 1.52T¥ 1.30T
Gross Profit
¥ 1.56T¥ 1.59T¥ 1.31T¥ 1.23T¥ 1.04T
Operating Expenses
¥ 1.31T¥ 1.18T¥ 1.13T¥ 944.84B¥ 823.13B
Depreciation and Amortization
¥ 199.13B¥ 194.59B¥ 157.84B¥ 105.74B¥ 79.68B
EBITDA
¥ 462.67B¥ 614.29B¥ 282.45B¥ 337.39B¥ 297.83B
Operating Income
¥ 255.67B¥ 419.70B¥ 178.07B¥ 285.43B¥ 220.02B
Other Income/Expenses
¥ -224.44B¥ -43.11B¥ -153.10B¥ -153.07B¥ -63.13B
Pretax Income
¥ 31.24B¥ 376.59B¥ 24.97B¥ 132.36B¥ 156.89B
Net Income
¥ 50.75B¥ 291.54B¥ 17.05B¥ 98.71B¥ 124.09B
Per Share Metrics
Basic EPS
¥ 28.35¥ 162.77¥ 9.50¥ 54.24¥ 67.08
Diluted EPS
¥ 28.24¥ 162.22¥ 9.47¥ 54.09¥ 67.05
Weighted Average Shares Outstanding
 1.79B 1.79B 1.79B 1.82B 1.85B
Weighted Average Shares Outstanding (Diluted)
 1.80B 1.80B 1.80B 1.83B 1.85B
Currency in JPY

Astellas Pharma Earnings and Revenue History